$gern imetelstat is bound to become reference treatment in an area where there is no treatment (low and intermediate refractory MDS without ring sideroblasts, that is most of the cases). PDFUA upcoming. Should be a winner youtu.be/mZrluKBDncg

People will wake up to this one soon

I found something really exciting that has not been listed or mentioned in any press release/presentation/ summit video yet. This is straight from the CEO’s mouth. Expect a partnership announcement in Q2. $MAIA

This one aged nicely 👌

You either show monotherapy efficacy in oncology, or you live long enough to see your entire company pivot towards autoimmune disease

The FDA has granted fast track designation to CTX-009, a bispecific DLL4/VEGF-A antibody in combination with paclitaxel for the treatment of patients with metastatic or locally advanced biliary tract cancer following prior therapy. U.S. FDA #oncology onclive.com/view/fda-grant…

1/Lineage Cell Therapeutics presented promising data at the Foundation Fighting Blindness Gene Therapy innovation summit - as part of #ARVO2024, from its clinical study of RG6501 (OpRegen) - a retinal pigment epithelial Cell therapy aimed to treat age-related macular degeneration dry AMD. $LCTX $RHHBY $XBI

$xbi microcaps having one of those ugly days.

$xbi micro caps getting properly destroyed today. Again

THEY ARE GOING TO CUT RATES REGARDLESS OF 2% INFLATION❗️ The next FOMC meeting is June 12th. As I have mentioned in previous posts the macro data over the last weeks or even months have favoured a highly dovish pivot from Powell and the FED. At the last meeting Powell even

$XBI today is one of the most brutal days I've seen on small caps. Does anyone know what's going on?

$DAWN Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC)... - DAWN • BioPharmCatalyst biopharmcatalyst.com/company/DAWN/n…

$DAWN Expands Pipeline with Potential First-in-Class Clinical-Stage ADC Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers. ir.dayonebio.com/news-releases/…

$CATX Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma

$CATX Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive Melanoma

We live in a era where little make sense. BTC, which has despite what people say, no practical use, has a market cap of 2T. Meanwhile, the biotech sector is getting destroyed, manipulated and shorted to the ground. I genuinely hate the direction this world is getting

The recent actions taken by the Trump’s administration - including the ban on Harvard and huge cuts in NIH’s funding (🧵👇) are destroying both science and innovation in America. It’s heartbreaking to hear David R. Liu - the winner of the 2025 Breakthrough Prize in Life Sciences

It’s heartbreaking to hear David R. Liu - the winner of the 2025 Breakthrough Prize in Life Sciences and one of the top leading scientists & innovators of our lifetime, describes during his conversation with Walter Isaacson the irreversible damages and the crisis caused from the

Bio microcaps being hit extremely hard today